Cormorant Asset Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,000,000
| Closed | -$9.75M | – | 49 |
|
|
2023
Q3 | $9.75M | Hold |
1,000,000
| – | – | 0.57% | 35 |
|
|
2023
Q2 | $11.8M | Buy |
1,000,000
+300,000
| +43% | +$3.55M | 0.66% | 33 |
|
|
2023
Q1 | $7.55M | Sell |
700,000
-200,000
| -22% | -$2.16M | 0.5% | 43 |
|
|
2022
Q4 | $10.4M | Sell |
900,000
-550,000
| -38% | -$6.36M | 0.7% | 38 |
|
|
2022
Q3 | $21.6M | Buy |
1,450,000
+700,000
| +93% | +$10.4M | 1.51% | 25 |
|
|
2022
Q2 | $6.77M | Buy |
+750,000
| New | +$6.77M | 0.51% | 45 |
|